nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Esomeprazole—Barrett's esophagus	0.246	0.303	CbGbCtD
Tolterodine—CYP2C19—Omeprazole—Barrett's esophagus	0.145	0.179	CbGbCtD
Tolterodine—CYP2C9—Omeprazole—Barrett's esophagus	0.121	0.149	CbGbCtD
Tolterodine—CYP3A4—Esomeprazole—Barrett's esophagus	0.119	0.147	CbGbCtD
Tolterodine—CYP2D6—Omeprazole—Barrett's esophagus	0.11	0.136	CbGbCtD
Tolterodine—CYP3A4—Omeprazole—Barrett's esophagus	0.0701	0.0864	CbGbCtD
Tolterodine—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00537	0.033	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00537	0.033	CcSEcCtD
Tolterodine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00486	0.186	CbGpPWpGaD
Tolterodine—Dry eye—Omeprazole—Barrett's esophagus	0.00448	0.0275	CcSEcCtD
Tolterodine—Dry eye—Esomeprazole—Barrett's esophagus	0.00448	0.0275	CcSEcCtD
Tolterodine—Abnormal vision—Omeprazole—Barrett's esophagus	0.00423	0.026	CcSEcCtD
Tolterodine—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00423	0.026	CcSEcCtD
Tolterodine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00388	0.149	CbGpPWpGaD
Tolterodine—Dry skin—Omeprazole—Barrett's esophagus	0.00323	0.0198	CcSEcCtD
Tolterodine—Dry skin—Esomeprazole—Barrett's esophagus	0.00323	0.0198	CcSEcCtD
Tolterodine—Dysuria—Esomeprazole—Barrett's esophagus	0.00284	0.0175	CcSEcCtD
Tolterodine—Dysuria—Omeprazole—Barrett's esophagus	0.00284	0.0175	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00283	0.0174	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00283	0.0174	CcSEcCtD
Tolterodine—Weight increased—Omeprazole—Barrett's esophagus	0.00277	0.017	CcSEcCtD
Tolterodine—Weight increased—Esomeprazole—Barrett's esophagus	0.00277	0.017	CcSEcCtD
Tolterodine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00264	0.0162	CcSEcCtD
Tolterodine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00264	0.0162	CcSEcCtD
Tolterodine—Sinusitis—Esomeprazole—Barrett's esophagus	0.00254	0.0156	CcSEcCtD
Tolterodine—Sinusitis—Omeprazole—Barrett's esophagus	0.00254	0.0156	CcSEcCtD
Tolterodine—Hallucination—Esomeprazole—Barrett's esophagus	0.00242	0.0149	CcSEcCtD
Tolterodine—Hallucination—Omeprazole—Barrett's esophagus	0.00242	0.0149	CcSEcCtD
Tolterodine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.0024	0.0147	CcSEcCtD
Tolterodine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.0024	0.0147	CcSEcCtD
Tolterodine—Visual impairment—Omeprazole—Barrett's esophagus	0.00235	0.0144	CcSEcCtD
Tolterodine—Visual impairment—Esomeprazole—Barrett's esophagus	0.00235	0.0144	CcSEcCtD
Tolterodine—Flushing—Esomeprazole—Barrett's esophagus	0.00226	0.0139	CcSEcCtD
Tolterodine—Flushing—Omeprazole—Barrett's esophagus	0.00226	0.0139	CcSEcCtD
Tolterodine—Flatulence—Omeprazole—Barrett's esophagus	0.00209	0.0128	CcSEcCtD
Tolterodine—Flatulence—Esomeprazole—Barrett's esophagus	0.00209	0.0128	CcSEcCtD
Tolterodine—Angioedema—Esomeprazole—Barrett's esophagus	0.00194	0.0119	CcSEcCtD
Tolterodine—Angioedema—Omeprazole—Barrett's esophagus	0.00194	0.0119	CcSEcCtD
Tolterodine—Vertigo—Omeprazole—Barrett's esophagus	0.0019	0.0117	CcSEcCtD
Tolterodine—Vertigo—Esomeprazole—Barrett's esophagus	0.0019	0.0117	CcSEcCtD
Tolterodine—Palpitations—Esomeprazole—Barrett's esophagus	0.00187	0.0115	CcSEcCtD
Tolterodine—Palpitations—Omeprazole—Barrett's esophagus	0.00187	0.0115	CcSEcCtD
Tolterodine—Chest pain—Omeprazole—Barrett's esophagus	0.0018	0.0111	CcSEcCtD
Tolterodine—Chest pain—Esomeprazole—Barrett's esophagus	0.0018	0.0111	CcSEcCtD
Tolterodine—Arthralgia—Omeprazole—Barrett's esophagus	0.0018	0.0111	CcSEcCtD
Tolterodine—Arthralgia—Esomeprazole—Barrett's esophagus	0.0018	0.0111	CcSEcCtD
Tolterodine—Anxiety—Esomeprazole—Barrett's esophagus	0.0018	0.011	CcSEcCtD
Tolterodine—Anxiety—Omeprazole—Barrett's esophagus	0.0018	0.011	CcSEcCtD
Tolterodine—Dry mouth—Esomeprazole—Barrett's esophagus	0.00176	0.0108	CcSEcCtD
Tolterodine—Dry mouth—Omeprazole—Barrett's esophagus	0.00176	0.0108	CcSEcCtD
Tolterodine—Confusional state—Esomeprazole—Barrett's esophagus	0.00174	0.0107	CcSEcCtD
Tolterodine—Confusional state—Omeprazole—Barrett's esophagus	0.00174	0.0107	CcSEcCtD
Tolterodine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00173	0.0106	CcSEcCtD
Tolterodine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00173	0.0106	CcSEcCtD
Tolterodine—Infection—Omeprazole—Barrett's esophagus	0.00172	0.0106	CcSEcCtD
Tolterodine—Infection—Esomeprazole—Barrett's esophagus	0.00172	0.0106	CcSEcCtD
Tolterodine—Tachycardia—Esomeprazole—Barrett's esophagus	0.00169	0.0104	CcSEcCtD
Tolterodine—Tachycardia—Omeprazole—Barrett's esophagus	0.00169	0.0104	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00158	0.00968	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00158	0.00968	CcSEcCtD
Tolterodine—Somnolence—Esomeprazole—Barrett's esophagus	0.00154	0.00944	CcSEcCtD
Tolterodine—Somnolence—Omeprazole—Barrett's esophagus	0.00154	0.00944	CcSEcCtD
Tolterodine—Dyspepsia—Omeprazole—Barrett's esophagus	0.00152	0.00935	CcSEcCtD
Tolterodine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00152	0.00935	CcSEcCtD
Tolterodine—Fatigue—Esomeprazole—Barrett's esophagus	0.00149	0.00916	CcSEcCtD
Tolterodine—Fatigue—Omeprazole—Barrett's esophagus	0.00149	0.00916	CcSEcCtD
Tolterodine—Constipation—Omeprazole—Barrett's esophagus	0.00148	0.00908	CcSEcCtD
Tolterodine—Constipation—Esomeprazole—Barrett's esophagus	0.00148	0.00908	CcSEcCtD
Tolterodine—Pain—Omeprazole—Barrett's esophagus	0.00148	0.00908	CcSEcCtD
Tolterodine—Pain—Esomeprazole—Barrett's esophagus	0.00148	0.00908	CcSEcCtD
Tolterodine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00143	0.00875	CcSEcCtD
Tolterodine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00143	0.00875	CcSEcCtD
Tolterodine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00141	0.00869	CcSEcCtD
Tolterodine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00141	0.00869	CcSEcCtD
Tolterodine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00137	0.0084	CcSEcCtD
Tolterodine—Abdominal pain—Omeprazole—Barrett's esophagus	0.00137	0.0084	CcSEcCtD
Tolterodine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00127	0.00783	CcSEcCtD
Tolterodine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00127	0.00783	CcSEcCtD
Tolterodine—Asthenia—Omeprazole—Barrett's esophagus	0.00124	0.00762	CcSEcCtD
Tolterodine—Asthenia—Esomeprazole—Barrett's esophagus	0.00124	0.00762	CcSEcCtD
Tolterodine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00118	0.00727	CcSEcCtD
Tolterodine—Diarrhoea—Omeprazole—Barrett's esophagus	0.00118	0.00727	CcSEcCtD
Tolterodine—Dizziness—Esomeprazole—Barrett's esophagus	0.00114	0.00703	CcSEcCtD
Tolterodine—Dizziness—Omeprazole—Barrett's esophagus	0.00114	0.00703	CcSEcCtD
Tolterodine—Headache—Esomeprazole—Barrett's esophagus	0.00108	0.00666	CcSEcCtD
Tolterodine—Headache—Omeprazole—Barrett's esophagus	0.00108	0.00666	CcSEcCtD
Tolterodine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000605	0.0232	CbGpPWpGaD
Tolterodine—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00056	0.0215	CbGpPWpGaD
Tolterodine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000527	0.0202	CbGpPWpGaD
Tolterodine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000527	0.0202	CbGpPWpGaD
Tolterodine—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000511	0.0196	CbGpPWpGaD
Tolterodine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000367	0.0141	CbGpPWpGaD
Tolterodine—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000362	0.0139	CbGpPWpGaD
Tolterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000347	0.0133	CbGpPWpGaD
Tolterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000347	0.0133	CbGpPWpGaD
Tolterodine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000337	0.0129	CbGpPWpGaD
Tolterodine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000334	0.0128	CbGpPWpGaD
Tolterodine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000333	0.0128	CbGpPWpGaD
Tolterodine—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00033	0.0127	CbGpPWpGaD
Tolterodine—KCNH2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000315	0.0121	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.00031	0.0119	CbGpPWpGaD
Tolterodine—CHRM5—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000304	0.0117	CbGpPWpGaD
Tolterodine—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000297	0.0114	CbGpPWpGaD
Tolterodine—CHRM4—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000292	0.0112	CbGpPWpGaD
Tolterodine—CHRM5—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00028	0.0107	CbGpPWpGaD
Tolterodine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000273	0.0105	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000272	0.0104	CbGpPWpGaD
Tolterodine—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000271	0.0104	CbGpPWpGaD
Tolterodine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000241	0.00923	CbGpPWpGaD
Tolterodine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000221	0.00845	CbGpPWpGaD
Tolterodine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000218	0.00834	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000214	0.00822	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000214	0.00819	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000197	0.00755	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000196	0.00753	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000195	0.00746	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000192	0.00735	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000191	0.00732	CbGpPWpGaD
Tolterodine—CHRM4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000181	0.00696	CbGpPWpGaD
Tolterodine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000179	0.00685	CbGpPWpGaD
Tolterodine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000173	0.00664	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000168	0.00643	CbGpPWpGaD
Tolterodine—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000158	0.00605	CbGpPWpGaD
Tolterodine—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000156	0.00597	CbGpPWpGaD
Tolterodine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000145	0.00557	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000144	0.00553	CbGpPWpGaD
Tolterodine—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000144	0.00552	CbGpPWpGaD
Tolterodine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000143	0.00549	CbGpPWpGaD
Tolterodine—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000142	0.00544	CbGpPWpGaD
Tolterodine—CHRM4—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000138	0.0053	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000138	0.0053	CbGpPWpGaD
Tolterodine—CHRM5—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000132	0.00507	CbGpPWpGaD
Tolterodine—KCNH2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000123	0.0047	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—SST—Barrett's esophagus	0.000121	0.00463	CbGpPWpGaD
Tolterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000114	0.00438	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—SST—Barrett's esophagus	0.00011	0.00421	CbGpPWpGaD
Tolterodine—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00011	0.00421	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—SST—Barrett's esophagus	0.000105	0.00403	CbGpPWpGaD
Tolterodine—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.0001	0.00384	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.73e-05	0.00373	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.7e-05	0.00372	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.6e-05	0.00368	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.5e-05	0.00364	CbGpPWpGaD
Tolterodine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.37e-05	0.00359	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	9.32e-05	0.00357	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	9.29e-05	0.00356	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	9.2e-05	0.00353	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—GAST—Barrett's esophagus	9.06e-05	0.00347	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—GAST—Barrett's esophagus	8.68e-05	0.00333	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—GAST—Barrett's esophagus	8.23e-05	0.00315	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8e-05	0.00307	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—GAST—Barrett's esophagus	7.88e-05	0.00302	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	7.41e-05	0.00284	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	7.38e-05	0.00283	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—SST—Barrett's esophagus	7.31e-05	0.0028	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.3e-05	0.0028	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	7.08e-05	0.00271	CbGpPWpGaD
Tolterodine—CHRM4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.07e-05	0.00271	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	6.53e-05	0.0025	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—SST—Barrett's esophagus	6.21e-05	0.00238	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	6.11e-05	0.00234	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	6.09e-05	0.00233	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—GAST—Barrett's esophagus	6.03e-05	0.00231	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—SST—Barrett's esophagus	5.95e-05	0.00228	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—SST—Barrett's esophagus	5.64e-05	0.00216	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.62e-05	0.00215	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	5.55e-05	0.00213	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	5.53e-05	0.00212	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGES—Barrett's esophagus	5.48e-05	0.0021	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GAST—Barrett's esophagus	5.48e-05	0.0021	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—SST—Barrett's esophagus	5.4e-05	0.00207	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.38e-05	0.00206	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GAST—Barrett's esophagus	4.86e-05	0.00186	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	4.71e-05	0.0018	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GAST—Barrett's esophagus	4.65e-05	0.00178	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—CXCL8—Barrett's esophagus	4.28e-05	0.00164	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	4.19e-05	0.0016	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	4.17e-05	0.0016	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	4.15e-05	0.00159	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—SST—Barrett's esophagus	4.13e-05	0.00158	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—CXCL8—Barrett's esophagus	4.1e-05	0.00157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	3.8e-05	0.00146	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.79e-05	0.00145	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	3.79e-05	0.00145	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.78e-05	0.00145	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—SST—Barrett's esophagus	3.75e-05	0.00144	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.74e-05	0.00143	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.56e-05	0.00137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SST—Barrett's esophagus	3.33e-05	0.00128	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	3.32e-05	0.00127	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.28e-05	0.00126	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	3.28e-05	0.00126	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	3.27e-05	0.00125	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.25e-05	0.00125	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GAST—Barrett's esophagus	3.23e-05	0.00124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SST—Barrett's esophagus	3.19e-05	0.00122	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	3e-05	0.00115	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	2.89e-05	0.00111	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	2.88e-05	0.0011	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CXCL8—Barrett's esophagus	2.85e-05	0.00109	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.7e-05	0.00104	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.48e-05	0.000952	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.46e-05	0.000944	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.42e-05	0.000927	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.32e-05	0.000888	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SST—Barrett's esophagus	2.25e-05	0.000861	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SST—Barrett's esophagus	2.24e-05	0.000858	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SST—Barrett's esophagus	2.22e-05	0.00085	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCL8—Barrett's esophagus	2.2e-05	0.000842	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.14e-05	0.000822	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCL8—Barrett's esophagus	2.1e-05	0.000806	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2e-05	0.000765	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.95e-05	0.000746	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.82e-05	0.000698	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.79e-05	0.000686	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.78e-05	0.000681	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APC—Barrett's esophagus	1.76e-05	0.000676	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APC—Barrett's esophagus	1.69e-05	0.000647	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.63e-05	0.000625	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.63e-05	0.000623	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.62e-05	0.000623	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.61e-05	0.000617	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.57e-05	0.000602	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.48e-05	0.000568	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	1.48e-05	0.000566	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL8—Barrett's esophagus	1.46e-05	0.00056	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.43e-05	0.000549	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RELA—Barrett's esophagus	1.38e-05	0.000528	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARG—Barrett's esophagus	1.37e-05	0.000524	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RELA—Barrett's esophagus	1.32e-05	0.000505	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL8—Barrett's esophagus	1.3e-05	0.000497	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL8—Barrett's esophagus	1.24e-05	0.000476	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.19e-05	0.000456	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.18e-05	0.000454	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APC—Barrett's esophagus	1.17e-05	0.00045	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.17e-05	0.000449	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.08e-05	0.000412	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	9.29e-06	0.000356	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	9.26e-06	0.000355	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RELA—Barrett's esophagus	9.17e-06	0.000351	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—Barrett's esophagus	8.89e-06	0.000341	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	8.75e-06	0.000335	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	8.72e-06	0.000334	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL8—Barrett's esophagus	8.64e-06	0.000331	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.17e-06	0.000313	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.1e-06	0.000311	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—Barrett's esophagus	7.96e-06	0.000305	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—Barrett's esophagus	7.63e-06	0.000292	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.99e-06	0.000268	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.43e-06	0.000247	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.38e-06	0.000244	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	5.37e-06	0.000206	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	5.35e-06	0.000205	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.34e-06	0.000205	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—Barrett's esophagus	5.3e-06	0.000203	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.2e-06	0.000161	CbGpPWpGaD
